{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:09:36Z","timestamp":1762459776039,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jneuroim.2019.577087","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T18:00:52Z","timestamp":1572717652000},"page":"577087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases"],"prefix":"10.1016","volume":"338","author":[{"given":"Georg","family":"Pilz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Steger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wipfler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrzad","family":"Afazel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Haschke-Becher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Trinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Harrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2019.577087_bb0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00401-007-0258-x","article-title":"Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma","volume":"114","author":"Brunn","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2019.577087_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12987-015-0008-8","article-title":"The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis","volume":"12","author":"Dersch","year":"2015","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.jneuroim.2019.577087_bb0015","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1158\/1078-0432.CCR-09-0108","article-title":"CXCL13 and CXCL12 in central nervous system lymphoma patients","volume":"15","author":"Fischer","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2019.577087_bb0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jneuroim.2014.05.008","article-title":"Cerebrospinal fluid CXCL13 is a prognostic marker for aseptic meningitis","volume":"273","author":"Fujimori","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2019.577087_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1742-2094-11-103","article-title":"CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation","volume":"11","author":"Hytonen","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2019.577087_bb0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458510389102","article-title":"Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course","volume":"17","author":"Khademi","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2019.577087_bb0035","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458510389102","article-title":"Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course","volume":"17","author":"Khademi","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2019.577087_bb0040","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2019.577087_bb0045","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ttbdis.2018.04.008","article-title":"CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA","volume":"9","author":"Markowicz","year":"2018","journal-title":"Ticks Tick Borne Dis."},{"key":"10.1016\/j.jneuroim.2019.577087_bb0050","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/sj.bjc.6604621","article-title":"Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients","volume":"99","author":"Panse","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jneuroim.2019.577087_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12974-019-1405-8","article-title":"Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study","volume":"16","author":"Pilz","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2019.577087_bb0060","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1182\/blood-2013-01-476333","article-title":"CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma","volume":"121","author":"Rubenstein","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2019.577087_bb0065","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1182\/blood-2013-01-476333","article-title":"CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma","volume":"121","author":"Rubenstein","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jneuroim.2019.577087_bb0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00115-014-4020-z","article-title":"CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine","volume":"85","author":"Rupprecht","year":"2014","journal-title":"Nervenarzt"},{"issue":"12","key":"10.1016\/j.jneuroim.2019.577087_bb0075","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmi.2018.04.007","article-title":"Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme euroborreliosis. A systematic review and meta-analysis","volume":"24","author":"Rupprecht","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jneuroim.2019.577087_bb0080","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.0b013e318211c39a","article-title":"A prospective study on the role of CXCL13 in Lyme neuroborreliosis","volume":"76","author":"Schmidt","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2019.577087_bb0085","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1128\/JCM.00084-11","article-title":"Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid","volume":"49","author":"van Burgel","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jneuroim.2019.577087_bb0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00415-017-8669-7","article-title":"CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients","volume":"265","author":"Wagner","year":"2018","journal-title":"J. Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819301080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572819301080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:35:14Z","timestamp":1759048514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572819301080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":18,"alternative-id":["S0165572819301080"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577087","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2019.577087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577087"}}